Hess KR - Search Results

1

Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer.

Tabchy A, Valero V, Vidaurre T, Lluch A, Gomez H, Martin M, Qi Y, Barajas-Figueroa LJ, Souchon E, Coutant C, Doimi FD, Ibrahim NK, Gong Y, Hortobagyi GN, Hess KR, Symmans WF, Pusztai L. Tabchy A, et al. Among authors: hess kr. Clin Cancer Res. 2010 Nov 1;16(21):5351-61. doi: 10.1158/1078-0432.CCR-10-1265. Epub 2010 Sep 9. Clin Cancer Res. 2010. PMID: 20829329 Free PMC article. Clinical Trial.

2

Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer.

Vassilopoulou-Sellin R, Guinee VF, Klein MJ, Taylor SH, Hess KR, Schultz PN, Samaan NA. Vassilopoulou-Sellin R, et al. Among authors: hess kr. Cancer. 1993 May 15;71(10):3119-23. doi: 10.1002/1097-0142(19930515)71:10<3119::aid-cncr2820711037>3.0.co;2-8. Cancer. 1993. PMID: 8490842

3

TPDC-FuHu chemotherapy for the treatment of recurrent metastatic brain tumors.

Kaba SE, Kyritsis AP, Hess K, Yung WK, Mercier R, Dakhil S, Jaeckle KA, Levin VA. Kaba SE, et al. J Clin Oncol. 1997 Mar;15(3):1063-70. doi: 10.1200/JCO.1997.15.3.1063. J Clin Oncol. 1997. PMID: 9060546 Clinical Trial.

4

Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: favorable subsets of patients with unknown-primary carcinoma?

Lenzi R, Hess KR, Abbruzzese MC, Raber MN, Ordoñez NG, Abbruzzese JL. Lenzi R, et al. Among authors: hess kr. J Clin Oncol. 1997 May;15(5):2056-66. doi: 10.1200/JCO.1997.15.5.2056. J Clin Oncol. 1997. PMID: 9164218

5

Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: relationship to prognostic significance.

Lin H, Bondy ML, Langford LA, Hess KR, Delclos GL, Wu X, Chan W, Pershouse MA, Yung WK, Steck PA. Lin H, et al. Among authors: hess kr. Clin Cancer Res. 1998 Oct;4(10):2447-54. Clin Cancer Res. 1998. PMID: 9796977

6

p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer.

Spitz FR, Giacco GG, Hess K, Larry L, Rich TA, Janjan N, Cleary KR, Skibber JM. Spitz FR, et al. Among authors: hess k. Clin Cancer Res. 1997 Oct;3(10):1685-90. Clin Cancer Res. 1997. PMID: 9815551

7

Prognostic significance of glutathione S-transferase pi expression and subcellular localization in human gliomas.

Ali-Osman F, Brunner JM, Kutluk TM, Hess K. Ali-Osman F, et al. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2253-61. Clin Cancer Res. 1997. PMID: 9815622

8

Prognostic significance of p53 immunoreactivity in patients with glioma.

Kyritsis AP, Bondy ML, Hess KR, Cunningham JE, Zhu D, Amos CJ, Yung WK, Levin VA, Bruner JM. Kyritsis AP, et al. Among authors: hess kr. Clin Cancer Res. 1995 Dec;1(12):1617-22. Clin Cancer Res. 1995. PMID: 9815964

9

Phase I clinical and plasma and cellular pharmacological study of topotecan without and with granulocyte colony-stimulating factor.

Abbruzzese JL, Madden T, Sugarman SM, Ellis AL, Loughlin S, Hess KR, Newman RA, Zwelling LA, Raber MN. Abbruzzese JL, et al. Among authors: hess kr. Clin Cancer Res. 1996 Sep;2(9):1489-97. Clin Cancer Res. 1996. PMID: 9816325 Clinical Trial.

10

Gamma-ray mutagen sensitivity and survival in patients with glioma.

Sigurdson AJ, Bondy ML, Hess KR, Toms SA, Kyritsis AP, Gu J, Wang LE, Wang X, Adatto P, Bruner JL, Yung WK, Levin VA, Wei Q. Sigurdson AJ, et al. Among authors: hess kr. Clin Cancer Res. 1998 Dec;4(12):3031-5. Clin Cancer Res. 1998. PMID: 9865917

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

419 results

Search Page